Physician profile
Carlos Rish
NPI 1982757027
$1,282.94
in general payments reported to CMS, 2019-2025
11 companies · $56.55 in 2025
The $56.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.72 · 2020: $92.68 · 2021: $448 · 2022: $596 · 2024: $47.46 · 2025: $56.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $544.03 | 2022 | |
| Welch Allyn | $422.30 | 2021 | |
| Sanofi-Aventis U.S. LLC | $82.00 | 2019-2020 | |
| Novo Nordisk INC | $69.96 | 2020-2025 | Rybelsus |
| Merck Sharp & Dohme LLC | $46.31 | 2019-2024 | Vaxneuvance, Proquad, Gardasil 9 |
| Sanofi Pasteur INC. | $31.06 | 2021-2022 | |
| Organon LLC | $28.03 | 2021-2022 | |
| Lilly USA, LLC | $18.23 | 2024 | Mounjaro |
| Pfizer INC. | $16.49 | 2025 | |
| Redhill Biopharma INC. | $13.39 | 2024 | Talicia |
| Travere Therapeutics, INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Rish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.